Antiplatelet therapy trial to bring DES rivals together for greater good
This article was originally published in Clinica
Executive Summary
All four major US drug-eluting stent (DES) manufacturers are to work together on an independent, large-scale study designed to investigate the best use of dual antiplatelet therapy (DAPT).